Stand Up To Cancer Funds High-Risk Studies in $9.7M Round | GenomeWeb

NEW YORK (GenomeWeb News) – The cancer research fund-raising organization Stand Up To Cancer (SU2C) said today that its latest funding round of $9.7 million includes several grants to support genetics, genomics, and molecular oncology studies.

The grants give up to $750,000 over three years to young researchers who are engaging in "high-risk/high-reward" studies, and the winners were selected by a scientific advisory committee assembled by the American Association for Cancer Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.